142 related articles for article (PubMed ID: 31888240)
21. The rs2839698 Single Nucleotide Polymorphism of lncRNA H19 is Associated with Post-Operative Prognosis in T3 Gastric Adenocarcinoma.
Wang W; Yang Q; Huang Q; Zhang H; Zhang Z; Gao J; Ren W; Hu Y; Lin Y; Dang Y; Zhang F; Wang W; Wang L
Clin Lab; 2018 Jan; 64(1):105-112. PubMed ID: 29479897
[TBL] [Abstract][Full Text] [Related]
22. Polymorphisms in epidermal growth factor receptor (EGFR) and AKT1 as possible predictors of clinical outcome in advanced non-small-cell lung cancer patients treated with EGFR tyrosine kinase inhibitors.
Zhang X; Fan J; Li Y; Lin S; Shu P; Ni J; Qin S; Zhang Z
Tumour Biol; 2016 Jan; 37(1):1061-9. PubMed ID: 26269114
[TBL] [Abstract][Full Text] [Related]
23. An Analysis of Prognostic Factors in Patients with Ovarian Malignant Germ Cell Tumors Who Are Treated with Fertility-Preserving Surgery.
Yang ZJ; Liu ZC; Wei RJ; Li L
Gynecol Obstet Invest; 2016; 81(1):1-9. PubMed ID: 25967958
[TBL] [Abstract][Full Text] [Related]
24. Potentially functional genetic variants in ferroptosis-related CREB3 and GALNT14 genes predict survival of hepatitis B virus-related hepatocellular carcinoma.
Zhan S; Qiu M; Wei X; Wei J; Qin L; Jiang B; Wen Q; Chen P; Lin Q; Wei X; Zhou Z; Jiang Y; Liang X; Li R; Liu Y; Yu H
Cancer Med; 2023 Dec; 13(1):. PubMed ID: 38151984
[TBL] [Abstract][Full Text] [Related]
25. Evaluation of Prognostic Factors and Adjuvant Chemotherapy in Patients With Small Bowel Adenocarcinoma Who Underwent Curative Resection.
Aydin D; Sendur MA; Kefeli U; Unal OU; Tastekin D; Akyol M; Tanrikulu E; Ciltas A; Ustaalioglu BB; Uysal M; Esbag O; Yazilitas D; Tanrıverdi O; Bilici A; Arpaci E; Berk V; Yetisyigit T; Ozdemir NY; Oztop I; Alacacioglu A; Aydin O; Ozcelik M; Yildirim E; Dinc N; Gumus M
Clin Colorectal Cancer; 2017 Sep; 16(3):220-227. PubMed ID: 27670893
[TBL] [Abstract][Full Text] [Related]
26. Decreased circadian component Bmal1 predicts tumor progression and poor prognosis in human pancreatic ductal adenocarcinoma.
Li W; Liu L; Liu D; Jin S; Yang Y; Tang W; Gong L
Biochem Biophys Res Commun; 2016 Mar; 472(1):156-62. PubMed ID: 26915801
[TBL] [Abstract][Full Text] [Related]
27. Cytochrome P450 1B1 (CYP1B1) polymorphisms are associated with clinical outcome of docetaxel in non-small cell lung cancer (NSCLC) patients.
Vasile E; Tibaldi C; Leon GL; D'Incecco A; Giovannetti E
J Cancer Res Clin Oncol; 2015 Jul; 141(7):1189-94. PubMed ID: 25504507
[TBL] [Abstract][Full Text] [Related]
28. Preoperative serum C-reactive protein levels and post-operative lymph node ratio are important predictors of survival after pancreaticoduodenectomy for pancreatic ductal adenocarcinoma.
Sanjay P; de Figueiredo RS; Leaver H; Ogston S; Kulli C; Polignano FM; Tait IS
JOP; 2012 Mar; 13(2):199-204. PubMed ID: 22406601
[TBL] [Abstract][Full Text] [Related]
29. The Prognostic and Predictive Role of Epidermal Growth Factor Receptor in Surgical Resected Pancreatic Cancer.
Guo M; Luo G; Liu C; Cheng H; Lu Y; Jin K; Liu Z; Long J; Liu L; Xu J; Huang D; Ni Q; Yu X
Int J Mol Sci; 2016 Jul; 17(7):. PubMed ID: 27399694
[TBL] [Abstract][Full Text] [Related]
30. [Influence of apatinib and VEGFR2-906T>C polymorphism on clinical outcomes of advanced non-small cell lung cancer patients].
Zhao RH; Zhou YN; Li H; Li R; Zhang WJ; Zong H
Zhonghua Yi Xue Za Zhi; 2019 Jan; 99(2):105-110. PubMed ID: 30669747
[No Abstract] [Full Text] [Related]
31. Prognostic significance of Wilms' tumor 1 expression in patients with pancreatic ductal adenocarcinoma.
Kanai T; Ito Z; Oji Y; Suka M; Nishida S; Takakura K; Kajihara M; Saruta M; Fujioka S; Misawa T; Akiba T; Yanagisawa H; Shimodaira S; Okamoto M; Sugiyama H; Koido S
Oncol Lett; 2018 Aug; 16(2):2682-2692. PubMed ID: 30008944
[TBL] [Abstract][Full Text] [Related]
32. Prognostic impact of carbohydrate sulfotransferase 15 in patients with pancreatic ductal adenocarcinoma.
Ito Z; Takakura K; Suka M; Kanai T; Saito R; Fujioka S; Kajihara M; Yanagisawa H; Misawa T; Akiba T; Koido S; Ohkusa T
Oncol Lett; 2017 Jun; 13(6):4799-4805. PubMed ID: 28599481
[TBL] [Abstract][Full Text] [Related]
33. NRP-1 and KDR polymorphisms are associated with survival time in patients with advanced gastric cancer.
Zhuo YJ; Shi Y; Wu T
Oncol Lett; 2019 Nov; 18(5):4629-4638. PubMed ID: 31611971
[TBL] [Abstract][Full Text] [Related]
34. Genetic variability of genes in NER pathway influences the treatment outcome of gastric cancer.
Xue MH; Li GY; Wu XJ; Zhang CX; Zhang CF; Zhu KX
Int J Clin Exp Pathol; 2015; 8(5):5563-9. PubMed ID: 26191265
[TBL] [Abstract][Full Text] [Related]
35.
Wu H; Ding F; Chen X; Chen S; Shi Z; Liu Q; Zheng Z; Chen Y
Oncol Lett; 2020 Jan; 19(1):121-126. PubMed ID: 31897122
[TBL] [Abstract][Full Text] [Related]
36. Influence of GSTP-1 Polymorphism on the Prognosis of Patients with High-Grade Glioma Who Received Temozolomide Plus Radiotherapy Adjuvant Treatment.
Zhi DB; Wang ZY; Xie T; Tu WW
Int J Gen Med; 2021; 14():10173-10183. PubMed ID: 35221710
[TBL] [Abstract][Full Text] [Related]
37. Increased tumour ADC value during chemotherapy predicts improved survival in unresectable pancreatic cancer.
Nishiofuku H; Tanaka T; Marugami N; Sho M; Akahori T; Nakajima Y; Kichikawa K
Eur Radiol; 2016 Jun; 26(6):1835-42. PubMed ID: 26385808
[TBL] [Abstract][Full Text] [Related]
38. GALNT14 genotype as a response predictor for concurrent chemoradiotherapy in advanced esophageal squamous cell carcinoma.
Tsou YK; Liang KH; Lin WR; Chang HK; Tseng CK; Yeh CT
Oncotarget; 2017 Apr; 8(17):29151-29160. PubMed ID: 28418863
[TBL] [Abstract][Full Text] [Related]
39. Clinical impact of different exosomes' protein expression in pancreatic ductal carcinoma patients treated with standard first line palliative chemotherapy.
Giampieri R; Piva F; Occhipinti G; Bittoni A; Righetti A; Pagliaretta S; Murrone A; Bianchi F; Amantini C; Giulietti M; Ricci G; Principato G; Santoni G; Berardi R; Cascinu S
PLoS One; 2019; 14(5):e0215990. PubMed ID: 31048929
[TBL] [Abstract][Full Text] [Related]
40. Genetic variants of NBS1 predict clinical outcome of platinum-based chemotherapy in advanced non-small cell lung cancer in Chinese.
Xu JL; Hu LM; Huang MD; Zhao W; Yin YM; Hu ZB; Ma HX; Shen HB; Shu YQ
Asian Pac J Cancer Prev; 2012; 13(3):851-6. PubMed ID: 22631660
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]